The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Seagen
Stock and Other Ownership Interests - Seagen
 
Consulting or Advisory Role - AstraZeneca; BMS Brazil; Eisai; GlaxoSmithKline; Ipsen; MSD; Pfizer; PharmaMar
Research Funding - AstraZeneca Canada (Inst); BMS Brazil (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Ipsen (Inst); MSD (Inst); Roche (Inst); Seagen (Inst)
Tisotumab vedotin (TV) + pembrolizumab (pembro) in first-line (1L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT Cx8/GOG 3024/innovaTV 205.
 
Domenica Lorusso
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; Corcept Therapeutics; Genmab; GlaxoSmithKline; Immunogen; Merck Serono; MSD; Oncoinvest; PharmaMar; Seagen; Sutro Biopharma
Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; PharmaMar
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Genmab (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Incyte (Inst); MSD (Inst); MSD (Inst); Novartis (Inst); PharmaMar (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; GlaxoSmithKline; GlaxoSmithKline; PharmaMar; Roche
(OPTIONAL) Uncompensated Relationships - Gynecological Cancer InterGroup
 
Ignace Vergote
Consulting or Advisory Role - Agenus; Akesobio - China; Amgen (Inst); AstraZeneca; Britol Myers Squibb; Carrick Therapeutics (Inst); Clovis Oncology (Inst); Deciphera (Inst); Eisai; Elevar Therapeutics; Genmab (Inst); GlaxoSmithKline; Immunogen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Mersana; Millennium (Inst); MSD; Novartis; Novocure; Octimet (Inst); Oncoinvent; Roche; Seagen; Sotio; Verastem (Inst); Zentalis
Research Funding - Amgen (Inst); Genmab (Inst); Oncoinvent (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; MSD/Merck; Roche; Tesaro
 
Roisin Eilish O'Cearbhaill
Honoraria - Curio Science; GlaxoSmithKline; MJH Life Sciences
Consulting or Advisory Role - Aptitude Health; Bayer; Carina Biotech; Fresenius Kabi; GlaxoSmithKline; Immunogen; Regeneron; Seagan
Research Funding - AstraZeneca/Merck (Inst); Atara Biotherapeutics (Inst); Bayer (Inst); Genentech (Inst); Genmab (Inst); GlaxoSmithKline (Inst); GOG Foundation (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Ludwig Institute for Cancer Research (Inst); Merck/Genentech (Inst); Regeneron (Inst); Sellas Life Sciences (Inst); Stem CentRx (Inst); Syndax (Inst); TapImmune Inc. (Inst); TCR2 Therapeutics (Inst)
Travel, Accommodations, Expenses - Hitech Health
 
Anneke M. Westermann
No Relationships to Disclose
 
Susana N. Banerjee
Honoraria - Amgen; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Immunogen; Mersana; MSD Oncology; Pfizer; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; GenMab; GlaxoSmithKline; Immunogen; Merck Serono; Mersana; MSD Oncology; OncXerna Therapeutics; Seagen; Shattuck Labs
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst)
 
Els Van Nieuwenhuysen
No Relationships to Disclose
 
David A Iglesias
Consulting or Advisory Role - Novocure
Research Funding - Aravive (Inst); Novocure (Inst); OncoQuest (Inst); Tesaro (Inst)
 
Dearbhaile Catherine Collins
Honoraria - Amgen; Genmab; Pfizer; Seagen; Takeda
Consulting or Advisory Role - Seagen
Research Funding - Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
David Cibula
Consulting or Advisory Role - Akeso Biopharma; AstraZeneca; GlaxoSmithKline; Mersana; MSD; Novocure; Roche; Sotio
 
Kristine Madsen
No Relationships to Disclose
 
Krishnansu Sujata Tewari
Honoraria - AstraZeneca; Clovis Oncology; Eisai; Genmab; Merck; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Roche/Genentech; Tesaro
Speakers' Bureau - AstraZeneca; Clovis Oncology; Eisai; Genmab; Merck; Roche/Genentech; Tesaro
Research Funding - Abbvie (Inst); Genentech/Roche (Inst); Merck (Inst); Morphotek (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Sandro Pignata
Honoraria - AstraZeneca; MSD; pfizer; pharmamar; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Pfizer; PharmaMar; Roche; tesaro
Research Funding - AstraZeneca (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
 
Jean-Francois Baurain
Consulting or Advisory Role - AstraZeneca Canada (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Immunocore (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Regeneron (Inst); Sanofi (Inst); Sun Pharma (Inst)
 
Ingrid A. Boere
Consulting or Advisory Role - AstraZeneca (Inst); Tesaro/GSK (Inst)
Research Funding - GlaxoSmithKline (Inst)
 
Hannelore denys
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Teva (Inst)
 
Camilla Mondrup Andreassen
Employment - Genmab
Honoraria - Genmab
 
Ibrahima Soumaoro
Employment - Genmab
Stock and Other Ownership Interests - Bristol-Myers Squibb; Genmab
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genmab
 
Shweta Jain
No Relationships to Disclose
 
Christine N. Gennigens
No Relationships to Disclose
 
Bradley J. Monk
Leadership - US Oncology
Honoraria - Agenus; Akeso Biopharma; Amgen; Aravive; AstraZeneca; Bayer; Clovis Oncology; Eisai; Elevar Therapeutics; EMD Serono/Merck; Genmab/Seattle Genetics; GOG Foundation; Gradalis; ImmunoGen; Iovance Biotherapeutics; Karyopharm Therapeutics; Macrogenics; Merck; Mersana; Myriad Pharmaceuticals; Novocure; Pfizer; Puma Biotechnology; Regeneron; Roche/Genentech; Sorrento Therapeutics; TESARO/GSK; US Oncology; Vascular Biogenics
Consulting or Advisory Role - Agenus; Akeso Biopharma; Amgen; Aravive; AstraZeneca; Bayer; Clovis Oncology; Eisai; Elevar Therapeutics; EMD Serono/Merck; Genmab/Seattle Genetics; GOG Foundation; Gradalis; Gradalis; ImmunoGen; Iovance Biotherapeutics; Karyopharm Therapeutics; Merck; Mersana; Myriad Pharmaceuticals; Novocure; Pfizer; Puma Biotechnology; Regeneron; Roche/Genentech; Sorrento Therapeutics; TESARO/GSK; US Oncology; Vascular Biogenics
Speakers' Bureau - AstraZeneca; Clovis Oncology; Eisai; Merck; Roche/Genentech; TESARO/GSK
Research Funding - Advaxis (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Regeneron (Inst); Tesaro (Inst)